4D Molecular Therapeutics FDMT
NASDAQ FDMT
$13.67 -0.17 (-1.23%)
At close: Oct 2, 2026 · 4:00 PM EDT

4D Molecular Therapeutics (FDMT) Change in Accured Expenses (2020 - 2026)

Updated

4D Molecular Therapeutics' Change in Accured Expenses was $6.54 million in Q2 2026, up 110.4% from $3.11 million a year earlier.

Analysis

4D Molecular Therapeutics (FDMT) Change in Accured Expenses (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, 4D Molecular Therapeutics' Change in Accured Expenses was $9.78 million through Jun 30, 2026, up 49.5% year-over-year; for FY2025, it came in at $8.15 million, up 25.0% from FY2024.

  • Change in Accured Expenses has now increased for four consecutive years, with a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
  • In earlier years, Change in Accured Expenses was $6.52 million in FY2024 (+93.5%), $3.37 million in FY2023 (+35.7%), $2.49 million in FY2022 (+260.7%) and $689,000 in FY2021 (-63.7%).
  • The Q2 2026 figure marks the highest quarterly Change in Accured Expenses since Q3 2024.
  • Compared with a year earlier, Change in Accured Expenses was higher in two of the last four quarters, with growth averaging 48.5%.
  • The best year-over-year quarter for Change in Accured Expenses over five years was Q4 2022 (growth of 240.7%); the worst was Q3 2025 (a decline of 38.5%).
  • Per Business Quant data, FDMT's Change in Accured Expenses in the three quarters before Q2 2026 was -$4.12 million (Q1 2026), $2.37 million (Q4 2025) and $4.98 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn -
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 2.96 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 1.20 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn -
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 338.00 Mn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn -
10 4D Molecular Therapeutics 972.56 Mn -487.38 Mn - 6.54 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.54 Mn
Mar 31, 2026 -4.12 Mn
Dec 31, 2025 2.37 Mn
Sep 30, 2025 4.98 Mn
Jun 30, 2025 3.11 Mn
Mar 31, 2025 -2.31 Mn
Dec 31, 2024 -2.37 Mn
Sep 30, 2024 8.11 Mn
Jun 30, 2024 3.17 Mn
Mar 31, 2024 -2.39 Mn
Dec 31, 2023 2.00 Mn
Sep 30, 2023 3.61 Mn
Jun 30, 2023 1.16 Mn
Mar 31, 2023 -3.40 Mn
Dec 31, 2022 1.82 Mn
Sep 30, 2022 1.08 Mn
Jun 30, 2022 652,000.00
Mar 31, 2022 -1.07 Mn
Dec 31, 2021 535,000.00
Sep 30, 2021 1.06 Mn
API Access

4D Molecular Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=FDMT&period=max&api_key=YOUR_API_KEY